Perry, Rachel J.
Rabin-Court, Aviva
Song, Joongyu D.
Cardone, Rebecca L.
Wang, Yongliang
Kibbey, Richard G.
Shulman, Gerald I. http://orcid.org/0000-0003-1529-5668
Article History
Received: 2 March 2018
Accepted: 7 January 2019
First Online: 1 February 2019
Competing interests
: G.I.S. is on the Scientific Advisory Boards for Merck, NovoNordisk, AstraZeneca, Aegerion, iMBP, Jansen Research and Development and receives investigator-initiated support from Gilead Sciences, Merck and AstraZeneca. This study was funded by an investigator-initiated award to R.J.P. and G.I.S. from Astra Zeneca. The remaining authors declare no competing interests.